Skip to main content

Table 3 Individual results of upper-limb motor capacity (FMA, ARAT), patient-reported arm usage (MAL-14, mean AOU) and daily life performance of arm activity during sitting (arm duration ratio and impaired arm duration)

From: Clinical value of assessing motor performance in postacute stroke patients

 

MAL-14 (mean AOU)

FMA

ARAT

Arm duration ratio (impaired/unimpaired) during sitting (%)

Impaired arm duration (in sec) during sitting normalized per hour (sec/hour)

Patient 1

1.33

15

9

66

518

Patient 2

1.15

11

0

58

594

Patient 3

1.5

51

41

73

1107

Patient 4

0.43

9

0

56

918

Patient 5

0.93

38

28

52

546

Patient 6

1.62

62

54

94

1570

Patient 7

4.79

58

57

124

326

Patient 8

4.86

65

57

70

883

Patient 9

0.64

33

15

52

643

Patient 10

2.64

66

57

86

1346

Patient 11

4.36

66

57

89

1102

Patient 12

1.79

55

45

94

1156

Patient 13

2.14

51

46

64

873

Patient 14

0.62

11

3

67

760

Patient 15

0.54

13

2

59

640